LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
What's coming for 2013?
Still fresh into the New Year, experts from various fields and industries are busy looking into their crystal balls in an attempt to predict what the hot issues for the year will be, which sectors will experience growth, and what will be trending for 2013. The field of life sciences is no different from the next industry.

Above and beyond industry forecasts, there are other anticipated global issues in 2013 that will either directly, or indirectly, affect all businesses. How will 2013 turn out to be, now that President Barack Obama has won a second term in office in the United States? Will he be able to turn the seemingly inevitable fiscal cliff around? Like it or not, developments in the American economy will affect us all β€” across countries and businesses and industries. As such, many MNCs are looking to move their operations and set up base in Asia, after being confronted with shifting business paradigms, anemic sales, fiscal cliffs and flat markets in the West. We are no longer living in an era where the West dictates global developments. Instead, we are seeing the emergence of China, which is projected to become the biggest pharmaceutical market after the United States as soon as 2016. The Economist Intelligence Unit has also found that a local presence in China has translated into success for pharmaceutical companies in the last three years. The real question to ask is: How can one miss out on the Chinese boom?

Another thing that is happening this year - US$290 billion worth of sales are at risk because of patent expirations between 2012 and 2018, according to estimates by pharmaceutical researcher EvaluatePharma. 2013 alone will see the expiration of patents for around 120 drugs that currently have sales of US$29 billion annually, and EvaluatePharma expects that more than 70% of that total will be lost to generics β€” two of the main reasons why generics will be a hot topic for 2013. Ever more so, this is the time pharmaceutical companies need a fresh approach to research and development (R&D) if they wish to tide through the year.

There are many questions that are raised at the start of a new year that we do not have answers to. We aim to address a few of those in this issue that looks into the future. Read on to see what industry players and your fellow researchers have to say about the future of the life sciences in areas like generics and biosimilars β€” which we anticipate will be very hot topics this yearβ€” as with China's growth in the bioscience industry.

Sulastri Kamis
Asia Pacific Biotech News

Check out our new website at www.asiabiotech.com
Sign up for our mailing list to get updates at www.worldscientific.com/page/newsletter-sign-up
Air your views and suggestions by writing to in to the editorial team (Letters to the Editor) at biotech_edit@wspc.com

Click here for the complete issue.

news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy